These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17142982)

  • 1. Population pharmacokinetics of higher-dose mizoribine in healthy male volunteers.
    Honda M; Itoh H; Suzuki T; Hashimoto Y
    Biol Pharm Bull; 2006 Dec; 29(12):2460-4. PubMed ID: 17142982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of mizoribine in adult recipients of renal transplantation.
    Ishida K; Okamoto M; Ishibashi M; Hashimoto Y
    Clin Exp Nephrol; 2011 Dec; 15(6):900-6. PubMed ID: 21751083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of mizoribine in pediatric recipients of renal transplantation.
    Ishida K; Motoyama O; Shishido S; Tsuzuki K; Hashimoto Y
    Clin Exp Nephrol; 2012 Oct; 16(5):799-804. PubMed ID: 22367565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetic Analysis of Mizoribine in Chinese Renal Transplant Recipients.
    Liu L; Ren B; Zhang H; Li J; Fu Q; Jiang J; Deng S; Qiu J; Chen G; Fei J; Chen L; Wang C
    Transplant Proc; 2018 Oct; 50(8):2392-2397. PubMed ID: 30316364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese males.
    Koue T; Kubo M; Funaki T; Fukuda T; Azuma J; Takaai M; Kayano Y; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2154-8. PubMed ID: 17978491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients.
    Chen P; Xu X; Liu L; Wu J; Li J; Fu Q; Chen J; Wang C
    Eur J Clin Pharmacol; 2019 Mar; 75(3):363-369. PubMed ID: 30386911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
    Hesselink DA; van Gelder T; van Schaik RH; Balk AH; van der Heiden IP; van Dam T; van der Werf M; Weimar W; Mathot RA
    Clin Pharmacol Ther; 2004 Dec; 76(6):545-56. PubMed ID: 15592326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The true distribution volume and bioavailability of mizoribine in children with chronic kidney disease.
    Nagai T; Uemura O; Kaneda H; Ushijima K; Ohta K; Gotoh Y; Satomura K; Shimizu M; Fujieda M; Morooka M; Yamada T; Yamada M; Wada N; Hashimoto Y
    Clin Exp Nephrol; 2017 Oct; 21(5):884-888. PubMed ID: 27873037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of concentrative nucleoside transporter 1 gene polymorphism on oral bioavailability of mizoribine in stable kidney transplant recipients.
    Naito T; Tokashiki S; Mino Y; Otsuka A; Ozono S; Kagawa Y; Kawakami J
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):310-6. PubMed ID: 19912163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic characteristics of sirolimus in healthy Chinese subjects and renal transplant patients.
    Wang M; Duan BL; Yuan YJ; Su X; Zheng H; Wang FS; Sun H
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):433-41. PubMed ID: 27117038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.
    Saint-Marcoux F; Marquet P; Jacqz-Aigrain E; Bernard N; Thiry P; Le Meur Y; Rousseau A
    Clin Pharmacokinet; 2006; 45(9):905-22. PubMed ID: 16928152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.